Trial Profile
A retrospective study evaluating effect of renal function on the safety of regimens containing Pemetrexed
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Jul 2017
Price :
$35
*
At a glance
- Drugs Pemetrexed (Primary) ; Bevacizumab; Carboplatin; Cisplatin
- Indications Malignant-mesothelioma; Non-small cell lung cancer; Thymoma
- Focus Adverse reactions
- 11 Jul 2017 New trial record